Literature DB >> 16111476

Slow thrombin in solution.

James A Huntington1.   

Abstract

As a tool for understanding biological mechanisms, X-ray crystallography possesses unparalleled power to enlighten, resolve controversy and shift a field of study on to a secure new paradigm. Thanks largely to developments in crystallographic methods, the technique has become accessible to the general biochemist and we have thus witnessed an exponential increase in the number of protein structures deposited every year. It is now commonplace for several structures to be published of the same protein under different crystallization conditions, sometimes resulting in conflicting mechanistic interpretations. Such a controversy has arisen over thrombin's conformational response to Na+ co-ordination, and in this issue of Biochemical Journal, De Filippis and colleagues put the two structural models of thrombin allostery to the test by returning to the techniques of solution biochemistry.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16111476      PMCID: PMC1198944          DOI: 10.1042/BJ20051099

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  14 in total

1.  Crystal structure of the anticoagulant slow form of thrombin.

Authors:  Agustin O Pineda; Savvas N Savvides; Gabriel Waksman; Enrico Di Cera
Journal:  J Biol Chem       Date:  2002-08-29       Impact factor: 5.157

2.  Molecular dissection of Na+ binding to thrombin.

Authors:  Agustin O Pineda; Christopher J Carrell; Leslie A Bush; Swati Prasad; Sonia Caccia; Zhi-Wei Chen; F Scott Mathews; Enrico Di Cera
Journal:  J Biol Chem       Date:  2004-05-19       Impact factor: 5.157

3.  Effect of Na+ binding on the conformation, stability and molecular recognition properties of thrombin.

Authors:  Vincenzo De Filippis; Elisa De Dea; Filippo Lucatello; Roberta Frasson
Journal:  Biochem J       Date:  2005-09-01       Impact factor: 3.857

4.  Thrombin: can't live without it; probably die from it.

Authors:  Kenneth G Mann
Journal:  Chest       Date:  2003-09       Impact factor: 9.410

5.  Mutation of W215 compromises thrombin cleavage of fibrinogen, but not of PAR-1 or protein C.

Authors:  D Arosio; Y M Ayala; E Di Cera
Journal:  Biochemistry       Date:  2000-07-11       Impact factor: 3.162

6.  The affinity of protein C for the thrombin.thrombomodulin complex is determined in a primary way by active site-dependent interactions.

Authors:  Genmin Lu; Sotheavy Chhum; Sriram Krishnaswamy
Journal:  J Biol Chem       Date:  2005-02-10       Impact factor: 5.157

7.  Structural basis for the anticoagulant activity of the thrombin-thrombomodulin complex.

Authors:  P Fuentes-Prior; Y Iwanaga; R Huber; R Pagila; G Rumennik; M Seto; J Morser; D R Light; W Bode
Journal:  Nature       Date:  2000-03-30       Impact factor: 49.962

8.  The molecular basis of thrombin allostery revealed by a 1.8 A structure of the "slow" form.

Authors:  James A Huntington; Charles T Esmon
Journal:  Structure       Date:  2003-04       Impact factor: 5.006

9.  Crystal structure of anticoagulant thrombin variant E217K provides insights into thrombin allostery.

Authors:  Wendy J Carter; Timothy Myles; Craig S Gibbs; Lawrence L Leung; James A Huntington
Journal:  J Biol Chem       Date:  2004-04-09       Impact factor: 5.157

Review 10.  Directing thrombin.

Authors:  David A Lane; Helen Philippou; James A Huntington
Journal:  Blood       Date:  2005-06-30       Impact factor: 22.113

View more
  1 in total

1.  Thrombin allosteric modulation revisited: a molecular dynamics study.

Authors:  Hermes Luís Neubauer de Amorim; Paulo Augusto Netz; Jorge Almeida Guimarães
Journal:  J Mol Model       Date:  2009-10-09       Impact factor: 1.810

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.